ATE215814T1 - Galenische einzeldosierung zur lokalen hormontherapie der vaginalen trockenheit - Google Patents
Galenische einzeldosierung zur lokalen hormontherapie der vaginalen trockenheitInfo
- Publication number
- ATE215814T1 ATE215814T1 AT96933492T AT96933492T ATE215814T1 AT E215814 T1 ATE215814 T1 AT E215814T1 AT 96933492 T AT96933492 T AT 96933492T AT 96933492 T AT96933492 T AT 96933492T AT E215814 T1 ATE215814 T1 AT E215814T1
- Authority
- AT
- Austria
- Prior art keywords
- agent
- estrogen
- lipophilic
- pct
- suspension
- Prior art date
Links
- 206010047791 Vulvovaginal dryness Diseases 0.000 title abstract 2
- 238000001794 hormone therapy Methods 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 11
- 229940011871 estrogen Drugs 0.000 abstract 5
- 239000000262 estrogen Substances 0.000 abstract 5
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 4
- 239000000227 bioadhesive Substances 0.000 abstract 3
- 239000003349 gelling agent Substances 0.000 abstract 3
- 239000000725 suspension Substances 0.000 abstract 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- 229960005309 estradiol Drugs 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 239000008384 inner phase Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000012071 phase Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007901 soft capsule Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 239000006216 vaginal suppository Substances 0.000 abstract 1
- 229940120293 vaginal suppository Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
- Y10S977/797—Lipid particle
- Y10S977/798—Lipid particle having internalized material
- Y10S977/799—Containing biological material
- Y10S977/801—Drug
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9511732A FR2739558B1 (fr) | 1995-10-05 | 1995-10-05 | Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale |
| PCT/FR1996/001555 WO1997012600A1 (fr) | 1995-10-05 | 1996-10-04 | Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE215814T1 true ATE215814T1 (de) | 2002-04-15 |
Family
ID=9483283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96933492T ATE215814T1 (de) | 1995-10-05 | 1996-10-04 | Galenische einzeldosierung zur lokalen hormontherapie der vaginalen trockenheit |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6060077A (de) |
| EP (1) | EP0861067B1 (de) |
| JP (1) | JPH11514994A (de) |
| CN (1) | CN1198665A (de) |
| AT (1) | ATE215814T1 (de) |
| AU (1) | AU7220496A (de) |
| CA (1) | CA2233919A1 (de) |
| DE (1) | DE69620625D1 (de) |
| FR (1) | FR2739558B1 (de) |
| WO (1) | WO1997012600A1 (de) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6319513B1 (en) | 1998-08-24 | 2001-11-20 | The Procter & Gamble Company | Oral liquid mucoadhesive compounds |
| CA2418135C (en) | 2000-08-03 | 2011-09-20 | Antares Pharma Ipl Ag | Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| US7198801B2 (en) * | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
| US20040198706A1 (en) * | 2003-03-11 | 2004-10-07 | Carrara Dario Norberto R. | Methods and formulations for transdermal or transmucosal application of active agents |
| US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
| US20070225379A1 (en) * | 2001-08-03 | 2007-09-27 | Carrara Dario Norberto R | Transdermal delivery of systemically active central nervous system drugs |
| US7018992B2 (en) | 2000-12-15 | 2006-03-28 | Novo Nordisk A/S | Hormone composition |
| EP3747443A3 (de) | 2000-12-15 | 2021-03-03 | Novo Nordisk Health Care AG | Verwendung eines östrogens bei der herstellung einer östrogenhaltigen zusammensetzung zur behandlung von atrophischer vaginitis |
| US7658941B2 (en) * | 2002-05-01 | 2010-02-09 | Johnson & Johnson Consumer Companies, Inc. | Warming and nonirritating lubricant compositions and method of comparing irritation |
| US7005408B2 (en) * | 2002-05-01 | 2006-02-28 | Mcneil-Ppc, Inc. | Warming and nonirritating lubricant compositions and method of comparing irritation |
| CA2484318C (en) * | 2002-05-01 | 2014-01-28 | Mcneil-Ppc, Inc. | Warming and nonirritating lubricant antifungal gel compositions |
| US7417013B2 (en) * | 2002-05-01 | 2008-08-26 | Mcneil-Ppc, Inc. | Warming and nonirritating lubricant compositions and method of comparing irritation |
| US7695730B2 (en) * | 2002-05-01 | 2010-04-13 | Mcneil-Ppc, Inc. | Warming and nonirritating lubricant compositions and method of comparing irritation |
| US20040167039A1 (en) * | 2002-05-01 | 2004-08-26 | Nawaz Ahmad | Warming and nonirritating lubricant compositions and method of comparing irritation |
| US20040185065A1 (en) * | 2002-05-01 | 2004-09-23 | Nawaz Ahmad | Warming and nonirritating lubricant compositions and method of comparing irritation |
| MXPA04010890A (es) * | 2002-05-01 | 2005-07-14 | Johnson & Johnson | Composiciones lubricantes anhidras generadoras de calor y no irritantes. |
| AU2003239869A1 (en) * | 2002-05-23 | 2003-12-12 | Michael Holick | Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy |
| US20040242729A1 (en) * | 2003-05-30 | 2004-12-02 | 3M Innovative Properties Company | Stabilized particle dispersions containing surface-modified inorganic nanoparticles |
| JP5296314B2 (ja) * | 2003-07-17 | 2013-09-25 | バナー ファーマキャップス,インコーポレイティド | 制御放出製剤 |
| CA2538856C (en) * | 2003-10-10 | 2010-06-29 | Antares Pharma Ipl Ag | Transdermal pharmaceutical formulation for minimizing skin residues |
| US20090053163A1 (en) * | 2003-10-30 | 2009-02-26 | Nawaz Ahmad | Warming and nonirritating lubricant compositions and method of comparing irritation |
| US7425340B2 (en) * | 2004-05-07 | 2008-09-16 | Antares Pharma Ipl Ag | Permeation enhancing compositions for anticholinergic agents |
| US6949067B1 (en) | 2004-05-11 | 2005-09-27 | Dann Jeffrey A | Device and method for enhancing female sexual stimulation |
| US8147399B2 (en) | 2004-05-11 | 2012-04-03 | Gloth David A | Device and method for applying a biocompatible substance to a female stimulation device |
| US20060040904A1 (en) * | 2004-08-17 | 2006-02-23 | Ahmed Salah U | Vaginal cream compositions, kits thereof and methods of using thereof |
| US8022053B2 (en) * | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
| GT200500315A (es) * | 2004-11-02 | 2006-06-06 | Formas de dosificacion oral solidas que contienen una dosis baja de estradiol | |
| WO2006084082A1 (en) * | 2005-02-03 | 2006-08-10 | Duramed Pharmaceuticals, Inc. | Compositions of unconjugated estrogens and methods for their use |
| WO2007124250A2 (en) | 2006-04-21 | 2007-11-01 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
| WO2006125642A1 (en) | 2005-05-27 | 2006-11-30 | Antares Pharma Ipl Ag | Methods and apparatus for transdermal or transmucosal application of testosterone |
| CA2612380C (en) * | 2005-06-16 | 2017-06-06 | Warner Chilcott Company, Inc. | Estrogen compositions for vaginal administration |
| CN101232869B (zh) * | 2005-06-16 | 2016-03-02 | 沃纳奇尔科特有限责任公司 | 局部给药的凝胶组合物 |
| US20070036848A1 (en) * | 2005-08-12 | 2007-02-15 | Drugtech Corporation | Estrogen compositions and therapeutic methods of use thereof |
| US7851419B2 (en) * | 2005-09-12 | 2010-12-14 | Nawaz Ahmad | Substantially anhydrous sprayable personal lubricant |
| US20070059250A1 (en) * | 2005-09-12 | 2007-03-15 | Nawaz Ahmad | Sprayable personal lubricant |
| CN101351196B (zh) * | 2005-10-26 | 2013-07-03 | 班纳制药公司 | 作为胶囊填充物的基于亲脂性载体的双重控释基质系统 |
| WO2007076144A2 (en) * | 2005-12-27 | 2007-07-05 | Duramed Pharmaceuticals, Inc. | Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
| US20070172965A1 (en) * | 2006-01-23 | 2007-07-26 | Kangguo Cheng | Non-destructive trench volume determination and trench capacitance projection |
| US20070281008A1 (en) * | 2006-06-05 | 2007-12-06 | Lin Shun Y | Personal lubricant compositions and kits for providing personal lubrication |
| WO2008067991A2 (en) * | 2006-12-08 | 2008-06-12 | Antares Pharma Ipl Ag | Skin-friendly drug complexes for transdermal administration |
| DE102007055341A1 (de) * | 2007-11-19 | 2009-05-20 | Bayer Animal Health Gmbh | Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| EP2782584B1 (de) | 2011-11-23 | 2021-06-09 | TherapeuticsMD, Inc. | Natürliche kombinierte hormonersatzformulierungen und -therapien |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| RU2740059C2 (ru) * | 2012-06-18 | 2020-12-31 | Терапьютиксмд, Инк. | Капсулы с растворимым эстрадиолом для интравагинального введения |
| US10806697B2 (en) * | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) * | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) * | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| BR112015022946A8 (pt) | 2013-03-15 | 2022-11-29 | Warner Chilcott Co Llc | Forma de dosagem de cápsula de gelatina macia farmacêutica com goma guar modificada |
| BR112016009008B8 (pt) * | 2013-10-22 | 2023-01-31 | Therapeuticsmd Inc | Uso de estradiol e/ou hemi-hidrato de estradiol e de um agente solubilizante compreendendo um óleo de cadeia média para a preparação de um pessário para o tratamento de atrofia vulvovaginal e pessário que compreende estradiol |
| AR100562A1 (es) | 2014-05-22 | 2016-10-12 | Therapeuticsmd Inc | Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| KR20180100567A (ko) * | 2015-12-07 | 2018-09-11 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 질 삽입식 에스트라디올 약제학적 조성물 및 방법 |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1207231A (en) * | 1982-08-24 | 1986-07-08 | Hans W. Zulliger | Medicated suppository |
| US5019395A (en) * | 1988-03-08 | 1991-05-28 | Warner-Lambert Company | Compositions with enhanced penetration |
-
1995
- 1995-10-05 FR FR9511732A patent/FR2739558B1/fr not_active Expired - Fee Related
-
1996
- 1996-10-04 AT AT96933492T patent/ATE215814T1/de not_active IP Right Cessation
- 1996-10-04 WO PCT/FR1996/001555 patent/WO1997012600A1/fr not_active Ceased
- 1996-10-04 CA CA002233919A patent/CA2233919A1/fr not_active Abandoned
- 1996-10-04 DE DE69620625T patent/DE69620625D1/de not_active Expired - Lifetime
- 1996-10-04 AU AU72204/96A patent/AU7220496A/en not_active Abandoned
- 1996-10-04 JP JP9514039A patent/JPH11514994A/ja active Pending
- 1996-10-04 CN CN96197405.2A patent/CN1198665A/zh active Pending
- 1996-10-04 US US09/051,242 patent/US6060077A/en not_active Expired - Fee Related
- 1996-10-04 EP EP96933492A patent/EP0861067B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FR2739558A1 (fr) | 1997-04-11 |
| JPH11514994A (ja) | 1999-12-21 |
| FR2739558B1 (fr) | 1997-11-28 |
| CA2233919A1 (fr) | 1997-04-10 |
| EP0861067B1 (de) | 2002-04-10 |
| AU7220496A (en) | 1997-04-28 |
| US6060077A (en) | 2000-05-09 |
| CN1198665A (zh) | 1998-11-11 |
| EP0861067A1 (de) | 1998-09-02 |
| WO1997012600A1 (fr) | 1997-04-10 |
| DE69620625D1 (de) | 2002-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69620625D1 (de) | Galenische einzeldosierung zur lokalen hormontherapie der vaginalen trockenheit | |
| Mishell Jr et al. | Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol andd-norgestrel | |
| DE69605899D1 (de) | Gel zur lokalen hormontherapie der vaginalen trockenheit | |
| US4816257A (en) | Method for producing an in vivo environment suitable for human embryo transfer | |
| US4186742A (en) | Contraceptive-antivenereal disease tampon | |
| FR2728464B1 (fr) | Forme galenique unitaire, son procede d'obtention et ses utilisations | |
| ES2337129T3 (es) | Sistema de administracion de medicamento comprendiendo un estrogeno tetrahidroxilado para el uso en la anticoncepcion hormonal. | |
| DE69133214D1 (de) | Medikamente zur topischen anwendung von sexualhormonen zur behandlung des trockenen auges, und verfahren zu ihrer herstellung und anwendung | |
| PT92131B (pt) | Processo para a preparacao de meios para aplicacao transdermica contendo gestodeno | |
| JPH10510825A (ja) | 17β−エストラジオール前駆体の投与のための膣内薬剤送出製剤 | |
| EP1087773A4 (de) | Abgabeverfahren und formulierungen für vaginalwirkstoffe | |
| CN101351188A (zh) | 雌激素组合物和应用它们的治疗方法 | |
| Laurikka-Routti et al. | A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistry | |
| Ladipo et al. | Contraceptive implants | |
| Price et al. | Effect of the suppository base on progesterone delivery from the vagina | |
| Sitruk-Ware | Transdermal application of steroid hormones for contraception | |
| Murray | Natural progesterone: what role in women’s health care | |
| Lähteenmäki et al. | Novel delivery systems in contraception | |
| Simon et al. | Polysiloxane vaginal rings and cylinders for physiologic endometrial priming in functionally agonadal women | |
| Englund et al. | Endometrial effect of vaginal estriol treatment: a scanning electron microscopic study of the luminal surface | |
| Chvapil et al. | Collagen sponge in gynecologic use | |
| JPH024576B2 (de) | ||
| Zañartu et al. | Steroid release from polymer vaginal devices. Effect on fertility inhibition | |
| Potts et al. | Where next with long-acting steroids? | |
| Moghadam et al. | Advances in menopausal hormonal therapy delivery systems: a comparative review |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |